PanTHERA CryoSolutions Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$16.8M
PanTHERA CryoSolutions General Information
Description
Developer of a cryopreservation system designed to preserve small molecules used in clinical research and studies. The company designs and manufactures patented ice recrystallization inhibitors for use in the cryopreservation of cells, and tissues that maintain cellular function after extended frozen storage, enabling physicians to use less costly storage and transportation systems for cell therapeutics.
Contact Information
Website
www.pantheracryo.com(Operating Subsidiary)
Corporate Office
- Canadian Blood Services Building
- 8249 114 Street
- Edmonton, Alberta T6G 2R8
- Canada
Corporate Office
- Canadian Blood Services Building
- 8249 114 Street
- Edmonton, Alberta T6G 2R8
- Canada
PanTHERA CryoSolutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 04-Apr-2025 | $16.8M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Grant | 07-Jul-2023 | Completed | Generating Revenue | |||
| 4. Grant | 07-Mar-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 03-Dec-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
PanTHERA CryoSolutions Patents
PanTHERA CryoSolutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260146238-A1 | Urea-based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation | Pending | 27-Nov-2024 | ||
| WO-2026112740-A1 | Urea-based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation | Pending | 27-Nov-2024 | ||
| US-20260146239-A1 | Tertiary amide aldonamide based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation | Pending | 26-Nov-2024 | ||
| WO-2026112736-A1 | Tertiary amide aldonamide based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation | Pending | 26-Nov-2024 | C07D205/04 |
PanTHERA CryoSolutions Signals
PanTHERA CryoSolutions Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alberta Innovates | Other | |||
| Casdin Capital | Venture Capital | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator | |||
| Industrial Biotechnology Innovation Centre | Government | |||
| National Research Council of Canada Industrial Research Assistance Program | Government | Minority |
PanTHERA CryoSolutions FAQs
-
When was PanTHERA CryoSolutions founded?
PanTHERA CryoSolutions was founded in 2017.
-
Where is PanTHERA CryoSolutions headquartered?
PanTHERA CryoSolutions is headquartered in Edmonton, Canada.
-
What is the size of PanTHERA CryoSolutions?
PanTHERA CryoSolutions has 9 total employees.
-
What industry is PanTHERA CryoSolutions in?
PanTHERA CryoSolutions’s primary industry is Other Healthcare Services.
-
Is PanTHERA CryoSolutions a private or public company?
PanTHERA CryoSolutions is a Private company.
-
What is the current valuation of PanTHERA CryoSolutions?
The current valuation of PanTHERA CryoSolutions is .
-
What is PanTHERA CryoSolutions’s current revenue?
The current revenue for PanTHERA CryoSolutions is .
-
How much funding has PanTHERA CryoSolutions raised over time?
PanTHERA CryoSolutions has raised $4M.
-
Who are PanTHERA CryoSolutions’s investors?
Alberta Innovates, Casdin Capital, Creative Destruction Lab, Industrial Biotechnology Innovation Centre, and National Research Council of Canada Industrial Research Assistance Program are 5 of 6 investors who have invested in PanTHERA CryoSolutions.
-
When was PanTHERA CryoSolutions acquired?
PanTHERA CryoSolutions was acquired on 04-Apr-2025.
-
Who acquired PanTHERA CryoSolutions?
PanTHERA CryoSolutions was acquired by Biolife Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process